Sarah Skuli

Physician-Scientist @UCincyMedicine studying TP53 MT AML - come join the Skuli Lab! Alum @Pennmedicine (Carroll Lab) @HopkinsMed @jeansarry (Sarry Lab)

[Sarah Skuli @SarahSkuli]

Chemoresistance of TP53 mutant AML requires the mevalonate byproduct, GGPP, for an induction of an adaptive stress response - available online now at Leukemia! Thanks to all co-authors and funding support from @ASH_hematology @ConquerCancerFd @NIH

https://t.co/xpkeXMTVdO

[Sarah Skuli @SarahSkuli]

https://t.co/kpUg8EXRT2

[Sarah Skuli @SarahSkuli]

Aaron Schimmer and I are excited to organize an @ASH_hematology Scientific Workshop "Mitochondria and Metabolism in Blood Cancer and Normal Hematopoiesis - From Discovery to Patients" on Friday, 12/5/25, 3-6pm in Orlando. Link below - email us if you are interested in speaking!

[Sarah Skuli @SarahSkuli]

@DrAndyMatthews @AClementinaM @jeansarry @dalessandrolab @EstelleSaland @KatieLaiMD_MPH @KMaxwellLab @scxc_upenn @LeukemiaJnl

[Sarah Skuli @SarahSkuli]

Chemoresistance of TP53 mutant AML requires the mevalonate byproduct, GGPP, for an induction of an adaptive stress response - available online now at Leukemia! Thanks to all co-authors and funding support from @ASH_hematology @ConquerCancerFd @NIH

https://t.co/xpkeXMTVdO

[Sarah Skuli @SarahSkuli]

@DrAndyMatthews @AClementinaM @jeansarry @dalessandrolab @EstelleSaland @KatieLaiMD_MPH
@KMaxwellLab @scxc_upenn

[Sarah Skuli @SarahSkuli]

@DrAndyMatthews @bowman_rl @AClementinaM @jeansarry @dalessandrolab @EstelleSaland @KatieLaiMD_MPH @KMaxwellLab @scxc_upenn

[Sarah Skuli @SarahSkuli]

Excited to share our new preprint identifying the mevalonate pathway as essential for chemoresistance of TP53 mutant AML, a huge unmet need in the field. Big thanks to Martin Carroll and all co-authors! Thanks to #ASH #ASCO & #NIH for funding support.

https://t.co/g4yDVFa4tc

[Sarah Skuli @SarahSkuli]

@DrAndyMatthews @bowman_rl @AClementinaM @jeansarry @dalessandrolab @EstelleSaland

[Keith W Pratz MD @PratzKW]

Congratulations to Dr Sarah Skuli for her work on TP53 AML as presented as oral session today at #ASH2023. Huge unmet medical need. https://t.co/GEnhUxEqW0

[Anagha Inguva Sheth, PhD @AnaghaInguva]

Having strong women mentors and role models in this field is everything. I’m so lucky to have people like @lindemilesphd @SarahSkuli @MariaAmaya_27 @CLJonesLab #ASH23

[Penn Medicine MD @PennMDForum]

Today at #ASH23, hear @SarahSkuli present on TP53 mutant #AML (Abstract 408) at 10:45a PT and Dr. Stephen Schuster give updates on two clinical trials for follicular lymphoma (Abstracts 601, 603). #lymsm
@ASH_hematology @PennCancer

[Sarah Skuli @SarahSkuli]

@Pharmaceut_MDPI @PennMedicine @HopkinsMedicine @Cambridge_Uni @scxc_upenn

[Pharmaceuticals MDPI @Pharmaceut_MDPI]

👏You should definitely check out #article we have #RecentlyPublished "#Metformin and #Cancer, an Ambiguanidous Relationship" by @SarahSkuli et al.

Find full text at:
👉https://t.co/qvbKoE9SFR

@PennMedicine @HopkinsMedicine @Cambridge_Uni

[FrezzaLab @FrezzaLab]

Mitochondrial respiratory chain dysfunction alters ER sterol sensing and mevalonate pathway activity https://t.co/8yhyY5HWm9

[Sarah Skuli @SarahSkuli]

@Legally_Lizzy 😳😬

[Sarah Skuli @SarahSkuli]

@Legally_Lizzy you can hire someone for that

[Sarah Skuli @SarahSkuli]

@Legally_Lizzy this was the reason I never read them!! Haha

[Sarah Skuli @SarahSkuli]

@Legally_Lizzy eek hope I don't drain you 😜

[Sarah Skuli @SarahSkuli]

@Legally_Lizzy pretty sure I already had that convo with him. It's not sticking haha

[Sarah Skuli @SarahSkuli]

@Legally_Lizzy and weddings!!